Biocytogen
Highly Engaged Employees
Business Services · Massachusetts, United States · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
50C Audubon Rd, Wakefield, Massachusetts...Phone Number
(781) 587-3558Website
www.biocytogen.comRevenue
$488.8 MillionIndustry
About Biocytogen
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. is a global biotechnology company that drives the research and development of novel antibody-based therapeutics. The company has streamlined the drug development process through the use of RenMice for fully human antibody discovery, in vivo drug efficacy screening platforms and strong clinical development expertise. Biocytogens RenMice HiTS Platform aims to develop novel antibody drugs with first-in-class and/or best-in-class potential for more than 1000 targets, and has resulted in collaborations with dozens of partners worldwide. The company's pipeline includes 12 core products; two products are in phase II MRCTs and two products are in phase I. Headquartered in Beijing, Biocytogen has branches in Haimen Jiangsu, Shanghai, Boston, USA and Heidelberg, Germany.Explore more
SIC Code 87,873NAICS Code 54,541Show moreBiocytogen Org Chart
Compare Similar Companies to Biocytogen
Compare insights from companies similar to Biocytogen, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Biocytogen Tech Stack
A closer look at the technologies used by Biocytogen
See more technologies
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Biocytogen
Sign Up For FreeTo access detailed company insights
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. is a global biotechnology company that drives the research and development of novel antibody-based therapeutics. The company has streamlined the drug development process through the use of RenMice for fully human antibody discovery, in vivo drug efficacy screening platforms and strong clinical developm... Read More
